Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMC 2815647)

Published in J Clin Microbiol on December 09, 2009

Authors

A Sargent1, A Bailey, A Turner, M Almonte, C Gilham, H Baysson, J Peto, C Roberts, C Thomson, M Desai, J Mather, H Kitchener

Author Affiliations

1: Manchester Clinical Virology, Central Manchester University Hospitals NHS Foundation Trust, Manchester M13 9WL, United Kingdom. alex.sargent@cmft.nhs.uk

Articles citing this

Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review. BMJ (2011) 1.72

HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study. Br J Cancer (2011) 1.10

Comparison of clinical and analytical performance of the Abbott Realtime High Risk HPV test to the performance of hybrid capture 2 in population-based cervical cancer screening. J Clin Microbiol (2011) 1.08

Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test. Br J Cancer (2010) 0.88

Sensitive HPV genotyping based on the flow-through hybridization and gene chip. J Biomed Biotechnol (2012) 0.87

Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland. Br J Cancer (2013) 0.83

Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with Amplicor HPV and Hybrid Capture 2 assays for detection of high-grade lesions of the uterine cervix. J Clin Microbiol (2010) 0.82

Human papillomavirus viral load expressed as relative light units (RLU) correlates with the presence and grade of preneoplastic lesions of the uterine cervix in atypical squamous cells of undetermined significance (ASCUS) cytology. Eur J Clin Microbiol Infect Dis (2012) 0.79

Optimal positive cutoff points for careHPV testing of clinician- and self-collected specimens in primary cervical cancer screening: an analysis from rural China. J Clin Microbiol (2014) 0.76

Hybrid capture 2 test results after an initial equivocal RLU/CO value are dependent on age. Am J Clin Pathol (2013) 0.75

The PapilloCheck Assay for Detection of High-Grade Cervical Intraepithelial Neoplasia. J Clin Microbiol (2015) 0.75

Surveillance of human papilloma virus using reference laboratory data for the purpose of evaluating vaccine impact. Online J Public Health Inform (2014) 0.75

Articles cited by this

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46

The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73

Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med (1998) 11.61

Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst (2000) 5.32

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol (2009) 4.99

HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA (2000) 4.62

The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev (2003) 2.52

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA (2002) 2.37

Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J Clin Microbiol (2007) 2.27

Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer (2001) 2.26

Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. Cancer Epidemiol Biomarkers Prev (2002) 2.24

Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol (1998) 2.21

Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial. Br J Cancer (2008) 1.77

Detection of high-risk HPV types by the hybrid capture 2 test. J Med Virol (2001) 1.49

Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol (2004) 1.33

Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: a longitudinal study of 3,091 women. Int J Cancer (2002) 1.01

Articles by these authors

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer (1976) 22.55

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1998) 15.09

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet (2009) 13.51

Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med (1991) 12.89

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet (2008) 8.12

Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet (2001) 7.31

Cohort study analysis with a FORTRAN computer program. Int J Epidemiol (1986) 6.66

Apolipoproteins and ischaemic heart disease: implications for screening. Lancet (1994) 6.62

Autism screening questionnaire: diagnostic validity. Br J Psychiatry (1999) 6.61

Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ (2004) 6.48

Randomised controlled trial comparing cost effectiveness of general practitioners and nurse practitioners in primary care. BMJ (2000) 6.14

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06

Transcriptional profiling shows that Gcn4p is a master regulator of gene expression during amino acid starvation in yeast. Mol Cell Biol (2001) 6.05

Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study. BMJ (1994) 6.05

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83

Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J (1979) 5.58

Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet (2003) 5.39

Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J (1992) 5.05

Ciprofloxacin resistance in gonococci. Lancet (1990) 4.90

Systematic gain-of-function genetics in Drosophila. Development (1998) 4.71

A case-control family history study of autism. J Child Psychol Psychiatry (1994) 4.66

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer (2002) 4.18

Comparison of overweight and obesity prevalence in school-aged youth from 34 countries and their relationships with physical activity and dietary patterns. Obes Rev (2005) 3.97

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer (2008) 3.87

The cornea is not a piece of plastic. J Refract Surg (2000) 3.72

Micro-organisms in the Healthy Nose. Med Chir Trans (1895) 3.72

Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet (1995) 3.71

Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. Br J Cancer (1982) 3.61

Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science (1998) 3.58

Carbon monoxide in breath in relation to smoking and carboxyhaemoglobin levels. Thorax (1981) 3.49

Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell (2001) 3.34

Survey of medical training in cytopathology carried out by the journal Cytopathology. Cytopathology (2010) 3.32

Environment. Can we defy nature's end? Science (2001) 3.14

Comparison of out of hours care provided by patients' own general practitioners and commercial deputising services: a randomised controlled trial. I: The process of care. BMJ (1997) 3.03

Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer (2004) 3.03

Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet (2008) 2.96

Latent-class analysis of recurrence risks for complex phenotypes with selection and measurement error: a twin and family history study of autism. Am J Hum Genet (1995) 2.94

Disparities in cancer diagnosis and survival. Cancer (2001) 2.81

The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer (2005) 2.81

Urinary cotinine as marker of breathing other people's tobacco smoke. Lancet (1984) 2.74

A study of treatment failures following large loop excision of the transformation zone for the treatment of cervical intraepithelial neoplasia. Br J Obstet Gynaecol (1997) 2.71

Measuring performance to drive improvement: development of a clinical indicator set for general medicine. Intern Med J (2009) 2.66

Epidural abscess complicating insertion of epidural catheters. Br J Anaesth (2002) 2.65

How to reduce the stress of general dental practice: the need for research into the effectiveness of multifaceted interventions. Br Dent J (2006) 2.64

Low serum-vitamin-A and subsequent risk of cancer. Preliminary results of a prospective study. Lancet (1980) 2.60

Tracing the first stars with fluctuations of the cosmic infrared background. Nature (2005) 2.60

Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet (1993) 2.58

Association of hyperglycemia with increased mortality after severe burn injury. J Trauma (2001) 2.55

UK National Guidelines on the Management of Syphilis 2008. Int J STD AIDS (2008) 2.53

Inhaling habits among smokers of different types of cigarette. Thorax (1980) 2.50

A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease. Gut (2004) 2.42

Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial. Lancet (2001) 2.40

Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol (1997) 2.40

Childhood lead poisoning in Massachusetts communities: its association with sociodemographic and housing characteristics. Am J Public Health (1995) 2.39

Viral hepatitis. A staff hazard in dialysis units. Lancet (1967) 2.38

A broader phenotype of autism: the clinical spectrum in twins. J Child Psychol Psychiatry (1996) 2.38

Anopheles gambiae pilot gene discovery project: identification of mosquito innate immunity genes from expressed sequence tags generated from immune-competent cell lines. Proc Natl Acad Sci U S A (2000) 2.38

Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis. Lancet (1987) 2.34

2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol (2005) 2.33

Variable expression of the autism broader phenotype: findings from extended pedigrees. J Child Psychol Psychiatry (2000) 2.33

Comparison of out of hours care provided by patients' own general practitioners and commercial deputising services: a randomised controlled trial. II: The outcome of care. BMJ (1997) 2.29

Retinal thickness measurements from optical coherence tomography using a Markov boundary model. IEEE Trans Med Imaging (2001) 2.29

Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer (2006) 2.27

Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. N Engl J Med (1979) 2.25

Fishing in the stream of diabetes: from measuring insulin to the control of fetal organogenesis. Biochem Soc Trans (1996) 2.23

Price and consumption of cigarettes: a case for intervention? Br J Prev Soc Med (1974) 2.22

Gene-target recognition among members of the myc superfamily and implications for oncogenesis. Nat Genet (2000) 2.19

The growth of cells in serum-free hormone-supplemented media. Methods Enzymol (1979) 2.18

Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. Br J Cancer (2009) 2.18

Multidimensional Treatment Foster Care for Adolescents in English care: randomised trial and observational cohort evaluation. Br J Psychiatry (2013) 2.16

Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule. Biochemistry (1986) 2.14

Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group. Oncogene (1992) 2.13

Carboxyhaemoglobin levels and inhaling habits in cigarette smokers. Thorax (1978) 2.13

Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism (1979) 2.07

Nursing practice. Triage on trial. Nurs Times (1988) 2.06

Family pesticide use and childhood brain cancer. Arch Environ Contam Toxicol (1993) 2.04

Redefining the Guillain-Barré spectrum in children: neuroimaging findings of cranial nerve involvement. AJNR Am J Neuroradiol (2011) 2.03

Interventions for treating plantar heel pain. Cochrane Database Syst Rev (2003) 2.03

Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet (1985) 2.03

Survey of general practitioners' treatment of the discharging ear. Br Med J (Clin Res Ed) (1988) 2.02

The hygiene standard for chrysotile asbestos. Lancet (1978) 2.02

HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. Br J Cancer (2006) 1.99

Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. IARC Monogr Eval Carcinog Risk Chem Hum Suppl (1980) 1.99

Use of carboxyhaemoglobin levels to predict the development of diseases associated with cigarette smoking. Thorax (1975) 1.93

Pertussis notifications in Australia, 1991 to 1997. Commun Dis Intell (1997) 1.93

A six-center international study of treatment outcome in patients with clefts of the lip and palate: Part 5. General discussion and conclusions. Cleft Palate Craniofac J (1992) 1.92

National study of colorectal cancer genetics. Br J Cancer (2007) 1.92

Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol Appl Pharmacol (2001) 1.91

The Dublin Consensus Statement on vital issues relating to the collection of blood and plasma and the manufacture of plasma products. PLUS. Vox Sang (2010) 1.91